The Dry Powder Inhaler Device market size was valued at $837 million in 2020, and is anticipated to grow at a CAGR of 5.2% during the forecast period 2022-2027. The dry powder inhaler device industry growth rate is attributed to the rising demand for various dry powder inhalers owing to the rise in the incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis which is poised in bringing new opportunities. A dry powder inhaler (DPI) is a type of inhaler commonly used to deliver medications such as inhaled corticosteroids into the lungs. This inhaler is breath-activated. The medication is released only when you take a deep, fast breath in through the inhaler. Basically, a dry powdered inhaler (DPI) is an asthma treatment option for older kids and teens as using this inhaler allows the medicine to get deep into the lungs. Unlike other inhalers which deliver a puff of medicine, these inhalers hold the medicine as a dry powder. Since the medicine sits inside as a powder, the user has to breathe in fast and deep to get the medicine into the lungs. Actually, the major benefit of a dry powder inhaler (DPI) is that it is used for the treatment of an increasingly diverse range of diseases. However, as drug delivery from a DPI involves a complex interaction between the device and the patient, the engineering development of this medical technology is proving to be a great challenge. Apart from this, with an increasing interest in high dose drug delivery, vaccination and systemic delivery via the lungs, innovative formulation technologies alone might not be sufficient. Hence, improved inhaler design is desired to make DPIs for future applications cost-effective and safe.
The factors such as the increase in demand for various dry powder inhalers owing to rising awareness of the incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, etc. are amongst the major factor projected to impel the growth of Dry Powder Inhaler Device market.
Additionally, factors such as improved inhaler design and innovative formulation technologies are to create opportunities paving a way for the growth in the market during the forecast period 2022-2027.
In 2020, on the basis of material type, the single-dose dry powder inhalers segment accounted for the largest segmental revenue of the Dry Powder Inhaler Devices Market . The single-dose dry powder inhalers held the largest market on account of the fact that this product type has a greater acceptability and wider market penetration than the other types. Also, the segment is to hold its dominance through the forecast period 2022-2027 as these dry powder inhalers are affordable and developing nations with moderate or low healthcare expenditures sectors can easily opt for such inhalers.
On the contrary, multi dose dry powder inhaler segment is projected to witness healthy growth throughout the forecast period 2022-2027 with a CAGR of 5.80% since the usage of multi dose dry powder inhaler has been on the upswing owing to the fact that there is an increasing demand and utilization of dry powder inhalers worldwide. Furthermore, its demand is poised to grow more as these inhalers are acts as an affordable devices for multiple places such as cars, homes, and job sites thereby, is to cater the sector growth in the material segment during the forecast period 2022-2027.
On the basis of distribution channel, the hospital pharmacies segment accounted for the largest segmental revenue of the Dry Powder Inhaler Market in 2020. The large share can be attributed to the consistent increase in the number of hospital pharmacies in countries such as Brazil, India, and China coupled with the rising number of prescriptions for dry powder inhalers by hospitals is attributed to positively affect market growth during the forecast period 2022-2027 owing to the presence of strong distribution channels and increased adoption preferences shown by doctors.
On the other hand, the e-commerce segment is projected to dominate over the forecast period 2022-2027 with a CAGR of 5.50%. The e-commerce segment is to witness a healthy growth owing to an increase in ease of use of retail e-commerce websites, rapid advancement observed in internet penetration, and growth in popularity of e-commerce shopping portals over the last decade. Moreover, the availability of a wide range of products and the presence of required support and information through expert customer service personnel coupled with the adoption of retail strategies, such as pricing and wide assortments by retailers is anticipated to positively impact the growth of this segmental market during the forecast period 2022-2027.
North America is the major region dominating the dry powder inhaler devices market with a market share of 35.69% in the year 2020. This can be attributed to the fact that the presence of well-established infrastructure, key market players as well the constantly investing into research and development activities. Furthermore, the rising prevalence of asthma and other respiratory diseases coupled with the increasing geriatric population as well as its adoption favor the U.S. dry powder inhaler devices market growth, which further fuels the regional market.
However, Asia-Pacific is projected to be the significant-growing market during the forecast period 2022-2027 as several countries such as India and China have a rising expenses on healthcare followed by rapidly enhancing medical infrastructure markets which are poised to propel the market growth throughout the Dry Powder Inhaler Devices Market forecast period 2022-2027.
The dry powder inhaler market is poised to receive an upswing owing to the rapid increase in demand for several DPI’s owing to an increasing prevalence of symptoms for emphysema, bronchitis, etc. amongst teenagers and adults that has resulted in all major pharmaceutical companies focusing on the R&D of innovative formulation technologies. Hence, there is a rising use of dry powder inhaler and is to propel the market growth over the forecast period 2022-2027.
One of the major factors lowering the dry powder inhaler in many countries around the world is owing to lack of awareness regarding the treatment availability decreases the demand for dry powder inhalers amongst the population that are obstructing market growth during the forecast period 2022-2027. Moreover, with the high demand in the for dry powder inhaler, the presence of effective substitutes are acting as challenges across the globe.
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Dry Powder Inhaler market. In 2020, Dry Powder Inhaler Devices market share is fragmented by the top ten players present in the market. The Dry Powder Inhaler Devices market top 10 companies are Astra Zeneca, Boehringer Ingelheim, Cheisi, Cipla, GlaxoSmithKline, Hovione, Mankind, 3M, OPKO, Teva and others.
In July 2020, Chemicals and biotechnology solutions firm Lonza recently launched a Center of Excellence for Dry Powder Inhaler (DPI) drug product development at its existing site in Bend, OR, where the company will use its expertise in particle engineering to help customers create and evaluate formulations.
In April 2019, Hovione Technology acquired the rights for the development and commercialization of an innovative multi-use blister-based, and ultra-affordable dry powder inhaler device (Papillon DPI) invented and patented by Dr. Klaus-Dieter Beller.
This product will be delivered within 2 business days.
Report Coverage
The report: “Dry Powder Inhaler Device Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Dry Powder Inhaler Device Market:
- By Product Type: Single Dose Dry Powder Inhaler and Multi Dose Dry Powder Inhaler
- By Application: Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others.
- By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies.
- By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan, India, South Korea, Australia and Others), South America(Brazil, Argentina and Others) and RoW (the Middle East and Africa).
Key Takeaways
The factors such as the increase in demand for various dry powder inhalers owing to rising awareness of the incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, etc. are amongst the major factor projected to impel the growth of Dry Powder Inhaler Device market.
Additionally, factors such as improved inhaler design and innovative formulation technologies are to create opportunities paving a way for the growth in the market during the forecast period 2022-2027.
Dry Powder Inhaler Device Market Segment Analysis - By Product Type
In 2020, on the basis of material type, the single-dose dry powder inhalers segment accounted for the largest segmental revenue of the Dry Powder Inhaler Devices Market . The single-dose dry powder inhalers held the largest market on account of the fact that this product type has a greater acceptability and wider market penetration than the other types. Also, the segment is to hold its dominance through the forecast period 2022-2027 as these dry powder inhalers are affordable and developing nations with moderate or low healthcare expenditures sectors can easily opt for such inhalers.
On the contrary, multi dose dry powder inhaler segment is projected to witness healthy growth throughout the forecast period 2022-2027 with a CAGR of 5.80% since the usage of multi dose dry powder inhaler has been on the upswing owing to the fact that there is an increasing demand and utilization of dry powder inhalers worldwide. Furthermore, its demand is poised to grow more as these inhalers are acts as an affordable devices for multiple places such as cars, homes, and job sites thereby, is to cater the sector growth in the material segment during the forecast period 2022-2027.
Dry Powder Inhaler Device Market Segment Analysis - By Distribution Channel
On the basis of distribution channel, the hospital pharmacies segment accounted for the largest segmental revenue of the Dry Powder Inhaler Market in 2020. The large share can be attributed to the consistent increase in the number of hospital pharmacies in countries such as Brazil, India, and China coupled with the rising number of prescriptions for dry powder inhalers by hospitals is attributed to positively affect market growth during the forecast period 2022-2027 owing to the presence of strong distribution channels and increased adoption preferences shown by doctors.
On the other hand, the e-commerce segment is projected to dominate over the forecast period 2022-2027 with a CAGR of 5.50%. The e-commerce segment is to witness a healthy growth owing to an increase in ease of use of retail e-commerce websites, rapid advancement observed in internet penetration, and growth in popularity of e-commerce shopping portals over the last decade. Moreover, the availability of a wide range of products and the presence of required support and information through expert customer service personnel coupled with the adoption of retail strategies, such as pricing and wide assortments by retailers is anticipated to positively impact the growth of this segmental market during the forecast period 2022-2027.
Dry Powder Inhaler Device Market Segment Analysis - By Geography
North America is the major region dominating the dry powder inhaler devices market with a market share of 35.69% in the year 2020. This can be attributed to the fact that the presence of well-established infrastructure, key market players as well the constantly investing into research and development activities. Furthermore, the rising prevalence of asthma and other respiratory diseases coupled with the increasing geriatric population as well as its adoption favor the U.S. dry powder inhaler devices market growth, which further fuels the regional market.
However, Asia-Pacific is projected to be the significant-growing market during the forecast period 2022-2027 as several countries such as India and China have a rising expenses on healthcare followed by rapidly enhancing medical infrastructure markets which are poised to propel the market growth throughout the Dry Powder Inhaler Devices Market forecast period 2022-2027.
Dry Powder Inhaler Device Market Drivers
Rapid Increase In Demand For DPI
The dry powder inhaler market is poised to receive an upswing owing to the rapid increase in demand for several DPI’s owing to an increasing prevalence of symptoms for emphysema, bronchitis, etc. amongst teenagers and adults that has resulted in all major pharmaceutical companies focusing on the R&D of innovative formulation technologies. Hence, there is a rising use of dry powder inhaler and is to propel the market growth over the forecast period 2022-2027.
Dry Powder Inhaler Device Market Challenges
Lack Of Awareness
One of the major factors lowering the dry powder inhaler in many countries around the world is owing to lack of awareness regarding the treatment availability decreases the demand for dry powder inhalers amongst the population that are obstructing market growth during the forecast period 2022-2027. Moreover, with the high demand in the for dry powder inhaler, the presence of effective substitutes are acting as challenges across the globe.
Dry Powder Inhaler Device Market Landscape
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Dry Powder Inhaler market. In 2020, Dry Powder Inhaler Devices market share is fragmented by the top ten players present in the market. The Dry Powder Inhaler Devices market top 10 companies are Astra Zeneca, Boehringer Ingelheim, Cheisi, Cipla, GlaxoSmithKline, Hovione, Mankind, 3M, OPKO, Teva and others.
Acquisitions/Product Launches
In July 2020, Chemicals and biotechnology solutions firm Lonza recently launched a Center of Excellence for Dry Powder Inhaler (DPI) drug product development at its existing site in Bend, OR, where the company will use its expertise in particle engineering to help customers create and evaluate formulations.
In April 2019, Hovione Technology acquired the rights for the development and commercialization of an innovative multi-use blister-based, and ultra-affordable dry powder inhaler device (Papillon DPI) invented and patented by Dr. Klaus-Dieter Beller.
This product will be delivered within 2 business days.
Table of Contents
1. Dry Powder Inhaler Devices Market - Overview
2. Dry Powder Inhaler Devices Market - Executive Summary
3. Dry Powder Inhaler Devices Market - Comparative Analysis
4. Dry Powder Inhaler Devices Market Forces
5. Dry Powder Inhaler Devices Market - Strategic Analysis
6. Dry Powder Inhaler Devices Market - By Product Type (Market Size -$Million/$Billion)
7. Dry Powder Inhaler Devices Market- By Application (Market Size -$Million/$Billion)
8. Dry Powder Inhaler Devices Market - By Distribution Channel (Market Size -$Million/$Billion)
9. Dry Powder Inhaler Devices Market - By Geography(Market Size -$Million/$Billion)
11. Dry Powder Inhaler Devices Market Company Analysis
Methodology
LOADING...
